• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鼻腔鼻窦黏膜黑色素瘤的淋巴结和远处转移:一项基于人群的分析。

Nodal and distant metastases in sinonasal mucosal melanoma: A population-based analysis.

机构信息

Department of Otolaryngology-Head and Neck Surgery, Mayo Clinic, Rochester, Minnesota, U.S.A.

出版信息

Laryngoscope. 2020 Mar;130(3):622-627. doi: 10.1002/lary.28065. Epub 2019 May 11.

DOI:10.1002/lary.28065
PMID:31077407
Abstract

OBJECTIVES/HYPOTHESIS: Sinonasal mucosal melanoma (SNMM) is a rare malignant neoplasm. No study to date has analyzed the impact that nodal metastases and distant metastases at diagnosis have on overall survival (OS) and disease-specific survival (DSS).

STUDY DESIGN

Retrospective database review.

METHODS

The Surveillance, Epidemiology, and End Results database was queried for cases of SNMM. Descriptive statistics were used analyze patient demographic and clinicopathologic variables. The Kaplan-Meier model was used to analyze survival, and the Cox proportional hazards model was used for multivariate analysis.

RESULTS

Three hundred twenty-eight cases of SNMM were identified. The most frequent sinonasal anatomic location was the nasal cavity in 279 (73.0%) patients, followed by the maxillary sinus in 60 (15.7%) patients. Regional nodal metastases at diagnosis occurred in 33 (8.6%) patients, whereas distant metastases at diagnosis occurred in 41 (10.7%) patients. Five-year OS was 22.7%, and 5-year DSS was 26.8%. The presence of positive nodes at diagnosis (OS P < .0001, DSS P < .0001), distant metastases at diagnosis (OS P = .0442, DSS P = .0442), primary tumor site (OS P < .0001, DSS P < .0001), and increasing age (OS P = .0012, DSS P = .0016) were found to be significant as negative predictors of OS and DSS.

CONCLUSIONS

SNMM is a rare pathologic entity with a poor prognosis. The presence of nodal and distant metastases at diagnosis are negative prognostic factors in OS and DSS. These factors can be used in the development of new models of risk stratification and to inform treatment strategies and surveillance patterns.

LEVEL OF EVIDENCE

NA Laryngoscope, 130:622-627, 2020.

摘要

目的/假设:鼻腔鼻窦黑色素瘤(SNMM)是一种罕见的恶性肿瘤。迄今为止,尚无研究分析诊断时的淋巴结转移和远处转移对总生存(OS)和疾病特异性生存(DSS)的影响。

研究设计

回顾性数据库研究。

方法

对 SNMM 病例进行监测、流行病学和最终结果数据库查询。使用描述性统计分析患者的人口统计学和临床病理变量。Kaplan-Meier 模型用于分析生存情况,Cox 比例风险模型用于多变量分析。

结果

共确定了 328 例 SNMM 患者。最常见的鼻腔鼻窦解剖部位是鼻腔 279 例(73.0%),其次是上颌窦 60 例(15.7%)。诊断时发生区域淋巴结转移 33 例(8.6%),诊断时发生远处转移 41 例(10.7%)。5 年 OS 为 22.7%,5 年 DSS 为 26.8%。诊断时存在阳性淋巴结(OS P <.0001,DSS P <.0001)、诊断时远处转移(OS P =.0442,DSS P =.0442)、原发肿瘤部位(OS P <.0001,DSS P <.0001)和年龄增加(OS P =.0012,DSS P =.0016)是 OS 和 DSS 的阴性预测因子。

结论

SNMM 是一种罕见的病理实体,预后不良。诊断时存在淋巴结和远处转移是 OS 和 DSS 的阴性预后因素。这些因素可用于开发新的风险分层模型,并为治疗策略和监测模式提供信息。

证据水平

NA Laryngoscope,130:622-627,2020。

相似文献

1
Nodal and distant metastases in sinonasal mucosal melanoma: A population-based analysis.鼻腔鼻窦黏膜黑色素瘤的淋巴结和远处转移:一项基于人群的分析。
Laryngoscope. 2020 Mar;130(3):622-627. doi: 10.1002/lary.28065. Epub 2019 May 11.
2
Localized sinonasal mucosal melanoma: Outcomes and associations with stage, radiotherapy, and positron emission tomography response.局限性鼻窦黏膜黑色素瘤:预后以及与分期、放疗和正电子发射断层扫描反应的相关性
Head Neck. 2016 Sep;38(9):1310-7. doi: 10.1002/hed.24435. Epub 2016 Apr 4.
3
Treatment modalities in sinonasal mucosal melanoma: A national cancer database analysis.治疗方式在鼻腔鼻窦黏膜黑色素瘤:国家癌症数据库分析。
Laryngoscope. 2020 Feb;130(2):275-282. doi: 10.1002/lary.27995. Epub 2019 Apr 25.
4
Patterns of Treatment Failure in Patients with Sinonasal Mucosal Melanoma.鼻腔鼻窦黏膜黑色素瘤患者的治疗失败模式。
Ann Surg Oncol. 2018 Jun;25(6):1723-1729. doi: 10.1245/s10434-018-6465-y. Epub 2018 Apr 6.
5
Oncologic outcomes, prognostic factor analysis and therapeutic algorithm evaluation of head and neck mucosal melanomas in France.法国头颈部黏膜黑色素瘤的肿瘤学结果、预后因素分析和治疗算法评估。
Eur J Cancer. 2019 Dec;123:1-10. doi: 10.1016/j.ejca.2019.09.007. Epub 2019 Oct 24.
6
Population-based analysis on the effect of nodal and distant metastases in sinonasal adenocarcinoma.基于人群的鼻窦腺癌区域淋巴结转移和远处转移影响分析。
Head Neck. 2021 Jan;43(1):128-136. doi: 10.1002/hed.26457. Epub 2020 Sep 15.
7
Impact of adjuvant therapy on survival for sinonasal mucosal melanoma.辅助治疗对鼻窦黏膜黑色素瘤生存的影响。
Acta Otolaryngol. 2020 Jan;140(1):79-84. doi: 10.1080/00016489.2019.1635269. Epub 2019 Nov 22.
8
Primary tumor volume as a predictor of distant metastases and survival in patients with sinonasal mucosal melanoma.原发性肿瘤体积作为鼻窦黏膜黑色素瘤患者远处转移和生存的预测指标。
Head Neck. 2020 Nov;42(11):3316-3325. doi: 10.1002/hed.26380. Epub 2020 Aug 1.
9
Approaches to regional lymph node metastasis in patients with head and neck mucosal melanoma.头颈部黏膜黑色素瘤患者区域淋巴结转移的处理方法。
Cancer. 2018 Feb 1;124(3):514-520. doi: 10.1002/cncr.31083. Epub 2017 Oct 17.
10
Cancer of the Nasal Cavity, Middle Ear and Accessory Sinuses - 15 Year Comparative Survival and Mortality Analysis by Age, Sex, Race, Stage, Grade, Cohort Entry Time-Period, Disease Duration and Topographic Primary Sites: A Systematic Review of 13,404 Cases for Diagnosis Years 2000-2017: (NCI SEER*Stat 8.3.8).鼻腔、中耳和副鼻窦癌症-15 年按年龄、性别、种族、分期、分级、队列进入时间-时期、疾病持续时间和解剖学原发部位比较生存和死亡率分析:2000-2017 年诊断年的 13404 例病例的系统评价:(NCI SEER*Stat 8.3.8)。
J Insur Med. 2024 Jul 1;51(2):77-91. doi: 10.17849/insm-51-2-77-91.1.

引用本文的文献

1
Disparities in the Receipt of Immunotherapy for Patients With Head and Neck Mucosal Melanoma.头颈部黏膜黑色素瘤患者免疫治疗接受情况的差异
Laryngoscope Investig Otolaryngol. 2025 Aug 7;10(4):e70232. doi: 10.1002/lio2.70232. eCollection 2025 Aug.
2
Epistaxis and Trismus Unmasking Metastatic Nasal Cavity Mucosal Melanoma Involving the Parapharyngeal Space.鼻出血和牙关紧闭揭示累及咽旁间隙的转移性鼻腔黏膜黑色素瘤
OTO Open. 2025 Jul 11;9(3):e70148. doi: 10.1002/oto2.70148. eCollection 2025 Jul-Sep.
3
Resectable Sinonasal Mucosal Melanoma in the Immunotherapy Era: Upfront Surgery vs. Neoadjuvant Therapy.
免疫治疗时代可切除的鼻窦黏膜黑色素瘤: upfront手术与新辅助治疗
Head Neck. 2025 Feb 5. doi: 10.1002/hed.28098.
4
Survival Outcomes in Sinonasal Mucosal Melanoma: Systematic Review and Meta-Analysis.鼻窦黏膜黑色素瘤的生存结局:系统评价与荟萃分析
J Pers Med. 2024 Nov 26;14(12):1120. doi: 10.3390/jpm14121120.
5
Sinonasal mucosal melanoma in The Netherlands between 2001 and 2021: a clinical and epidemiological overview of 320 cases.荷兰 2001 年至 2021 年的鼻腔鼻窦黏膜黑色素瘤:320 例临床和流行病学概述。
Eur Arch Otorhinolaryngol. 2024 Oct;281(10):5437-5446. doi: 10.1007/s00405-024-08717-7. Epub 2024 May 18.
6
From apparent pseudoprogression to durable complete remission of expansile destructive sinonasal mucosal melanoma under pembrolizumab after primary endoscopic resection: A case report.原发性内镜切除术后帕博利珠单抗治疗下扩张性破坏性鼻窦黏膜黑色素瘤从明显的假性进展到持久完全缓解:一例报告
SAGE Open Med Case Rep. 2024 May 12;12:2050313X241253471. doi: 10.1177/2050313X241253471. eCollection 2024.
7
Skull Base Tumors: Therapeutic Challenges and Multi-Disciplinary Care.颅底肿瘤:治疗挑战与多学科护理
Cancers (Basel). 2024 Jan 31;16(3):620. doi: 10.3390/cancers16030620.
8
Development and validation of a nomogram for predicting overall survival in patients with sinonasal mucosal melanoma.构建并验证预测鼻腔鼻窦黏膜黑色素瘤患者总生存的列线图。
BMC Cancer. 2024 Feb 7;24(1):184. doi: 10.1186/s12885-024-11888-5.
9
Multimodal treatment and immune checkpoint inhibition in sinonasal mucosal melanoma: real-world data of a retrospective, single-center study.多模态治疗联合免疫检查点抑制剂治疗鼻腔鼻窦黏膜黑色素瘤:一项回顾性单中心真实世界研究数据。
Eur Arch Otorhinolaryngol. 2023 Sep;280(9):4215-4223. doi: 10.1007/s00405-023-08015-8. Epub 2023 Jun 5.
10
Sinonasal malignancies: histopathological entities, regional involvement and long-term outcome.鼻窦恶性肿瘤:组织病理学实体、区域性累及和长期预后。
J Otolaryngol Head Neck Surg. 2023 Apr 28;52(1):36. doi: 10.1186/s40463-023-00627-8.